May 2026
📣 VC round data is live. Check it out!
Largest Hospitals & Clinics Public Companies in China
Benchmark revenue and EBITDA valuation multiples for public comps like
Aier EYE Hospital Group, Meinian Onehealth, Topchoice Medical, Huaxia Eye Hospital Group and Concord Medical.
 | Aier Eye Hospital Group Co Ltd provides international ophthalmic technology and management services in China. The company offers services in myopia surgery, cataract surgery, pediatric eye plastic surgery, myopia prevention, and control to patients. The group also enables high-standard medical care. | $2 | -13% | $15B | $15B | 4.5x | 15.4x | ||
| Meinian Onehealth Healthcare Holdings Co Ltd is engaged in the provision of physical examination and medical services. The firm provides health consultation, and health assessment services among others. | $1 | +22% | $4B | $4B | 2.7x | 12.6x | ||
| Topchoice Medical Corp is engaged in providing medical services. The company operates as an integrated medical platform with several oral, health, and reproductive medical institutions. | $6 | -2% | $3B | $3B | 6.2x | 19.4x | ||
| Huaxia Eye Hospital Group Co Ltd is a ophthalmic medical chain group in China. It offers ophthalmology specialist medical services. | $3 | -7% | $2B | $2B | 2.8x | 12.3x | ||
| Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC. | $0 | -79% | $143M | $554M | 8.2x | (112.7x) | ||
| Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services. | $5 | -29% | $22M | $514M | 7.6x | (48.6x) | ||
| Median | $2 | -10% | $2B | $2B | 5.3x | 12.5x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.